Results 91 to 100 of about 14,159 (238)

PYCR1 is associated with papillary renal cell carcinoma progression

open access: yesOpen Medicine, 2019
Abstract Objective We aimed to determine the function of pyrroline-5-carboxylate reductase 1 (PYCR1) on progression of papillary renal cell carcinoma (PRCC) and related mechanism. Methods The TCGA database provided us expression ...
Qiu-Li Wang, Ling Liu
openaire   +4 more sources

Epigenetically‐Upregulated CD98 Shed Light on the Precancerous Diagnosis and Prognosis Prediction of Esophageal Cancer

open access: yesCancer Science, EarlyView.
This study confirmed that hypomethylation‐induced upregulation of CD98 promoted ESCC cell proliferation by regulating the cell cycle and was correlated with poorer overall survival of ESCC patients. Combined panels of immunohistochemistry (CD98 and P53) are recommended for accurate diagnosis of esophageal precancerous lesions.
Xue Zhang   +13 more
wiley   +1 more source

Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Renal cell carcinoma associated with Xp11.2 translocations is frequently reported in children, but adult-onset is rare. Here, the case of an adult male who developed a renal cell carcinoma associated with Xp11.2 translocations is presented ...
Morii Akihiro   +4 more
doaj   +1 more source

Refining a proximal breakpoint cluster at chromosome 3p11.2 in non‐papillary renal cell carcinomas [PDF]

open access: bronze, 1996
Peter Bugert   +3 more
openalex   +1 more source

Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two‐Step Approach

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Calcitonin (CT) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. Procalcitonin (ProCT) has been recognized as an alternative or additional marker for MTC. The aim of the study is to evaluate prospectively the role of ProCT combined with CT in the identification of MTC ...
Cristina Clausi   +13 more
wiley   +1 more source

Adult Patient with Synchronous Gastrointestinal Stromal Tumor and Xp11 Translocation-Associated Renal Cell Carcinoma: A Unique Case Presentation with Discussion and Review of Literature

open access: yesCase Reports in Urology, 2015
Gastrointestinal stromal tumor (GIST) is the most common primary mesenchymal tumor of the gastrointestinal tract. This entity comprises a wide spectrum of tumors that vary from benign to overtly malignant, with the majority of these tumors harboring ...
Vanda Farahmand Torous   +3 more
doaj   +1 more source

Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study

open access: yesHistopathology, EarlyView.
Hybrid grading of papillary nonmuscle invasive bladder cancer showed substantial agreement as assessed by interrater kappa values. This suggests that urologic pathologists can readily adapt to using a three‐tier hybrid grading system. Aims A hybrid‐three tier system with low grade (LG), high grade‐ G2 (HG‐G2), high grade‐ G3 (HG‐G3) has been proposed ...
Michelle R. Downes   +19 more
wiley   +1 more source

Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes

open access: yesFrontiers in Oncology, 2019
Renal cell carcinomas (RCC) are heterogeneous and can be further classified into three major subtypes including clear cell, papillary and chromophobe. Signal transducer and activator of transcription 3 (STAT3) is commonly hyperactive in many cancers and ...
Rebekah L. Robinson   +9 more
doaj   +1 more source

Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP)

open access: yesHistopathology, EarlyView.
FH immunohistochemistry is recommended in clinically malignant Leydig cell tumours and in primary Leydig cell tumours with aggressive histopathologic features. Aims Testicular sex cord‐stromal tumours (TSCSTs) are relatively rare, accounting for ~5% of all testicular neoplasms.
Andres M Acosta   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy